Position Summary
Alnylam Pharmaceuticals is seeking an accomplished and visionary Vice President, Global Scientific Communications to lead the strategic development and execution of global scientific communication activities across our portfolio including the ATTR franchise and pipeline assets. Reporting directly to the Sr. Vice President, Head of Medical Affairs, this executive leader will oversee Medical Communications & Publications, Medical Information & Review, Medical Training, and the office of Grants and Sponsorships. They will play a critical role in advancing Alnylam's scientific leadership and reputation among healthcare professionals, researchers, and patient communities.
The successful candidate will be a highly strategic, scientifically sophisticated leader with extensive experience developing and executing integrated medical communication and publication strategies in support of innovative therapies. This individual will partner closely with Clinical Development, Commercial, Regulatory, and Corporate Communications teams to ensure the timely dissemination of high-quality scientific evidence about our products that supports patient care and advances the understanding of disease and treatment.
Key Responsibilities
- Develop and execute the long term integrated global strategy for Medical Communications, Publications, and Medical Information aligned with Alnylam's corporate and Medical Affairs objectives.
- Partner as a key member of the Medical Affairs Leadership Team to define strategy and drive organizational development.
- Build and retain a best-in-class scientific communications organization recognized for innovation, excellence, compliance, and scientific rigor.
- Interact with key societies and organizations related to publications and congresses
- Establish and chair publication governance structures and publication committees.
- Drive innovation in scientific engagement, digital communications, and omnichannel medical education approaches.
- Act as a senior scientific representative and thought leader to key external stakeholders.
- Foster a culture of scientific excellence, accountability, innovation, collaboration, and continuous learning.
- Build organizational capabilities to support Alnylam's continued growth and expanding portfolio.
- Lead an integrated medical channel and content strategy, ensuring scientific content from Medical Communications, Publications, and Medical Information is built efficiently and used across digital, field medical, and other medical affairs channels.
- Establish an integrated strategy for scientific & healthcare partnerships, grants and sponsorships, building trusted, compliant relationships with health systems, professional societies, and patient organizations across the portfolio and ahead of upcoming launches.
Qualifications
Required
- Advanced scientific or clinical degree (MD, PharmD, PhD, or equivalent).
- Minimum of 15 years of progressive experience in Medical Communications, Publications, Medical Affairs, Scientific Communications, or related functions within the pharmaceutical or biotechnology industry.
- Significant people leadership experience, including management of large, complex, and geographically dispersed teams.
- Demonstrated success developing and executing global publication and scientific communication strategies.
- Extensive experience leading publication planning, publication committees, and scientific dissemination activities.
- Proven expertise in engagement with key opinion leaders, academic investigators, and professional societies.
- Deep understanding of ICMJE, GPP, publication ethics, authorship standards, and industry regulations.
- Significant experience planning and leading major international scientific congresses.
- Strong executive presence and exceptional communication, collaboration, and influencing skills.
Preferred
- Experience within rare disease, specialty medicine, cardiovascular, neurology, or RNAi therapeutics.
- Demonstrated success building and transforming high-performing scientific communications organizations.
- Experience interacting with journal editors, editorial boards, and leading scientific publications.
- Global experience supporting multiple regions and cross-functional teams.
About Alnylam
We are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what’s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We're proud to be a globally recognized top employer, where an authentic, inclusive culture and breakthrough thinking fuel one another.
At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. Qualified applicants will receive consideration for employment without regard to their sex, gender or gender identity, sexual orientation, race, color, ethnicity, national origin, ancestry, citizenship, religion, creed, physical or mental disability, pregnancy status or related conditions, genetic information, veteran or military status, marital or familial status, political affiliation, age, or any other factor protected by federal, state, or local law. Alnylam is an E-Verify Employer.
Before applying, please review Alnylam's Candidate Privacy Notice regarding how Alnylam handles Personal Data you provide with your application for employment.
#LI-ST1 #LI-Hybrid
The pay range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).
Alnylam’s robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.
Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers
Skills Required
- Advanced scientific or clinical degree such as MD, PharmD, PhD, or equivalent
- At least 15 years of progressive experience in Medical Communications, Publications, Medical Affairs, Scientific Communications, or related pharmaceutical or biotechnology functions
- Significant people leadership experience managing large, complex, geographically dispersed teams
- Experience developing and executing global publication and scientific communication strategies
- Extensive experience leading publication planning, publication committees, and scientific dissemination activities
- Expertise engaging key opinion leaders, academic investigators, and professional societies
- Deep understanding of ICMJE, GPP, publication ethics, authorship standards, and industry regulations
- Experience planning and leading major international scientific congresses
- Strong executive presence and exceptional communication, collaboration, and influencing skills
- Experience in rare disease, specialty medicine, cardiovascular, neurology, or RNAi therapeutics
- Success building and transforming high-performing scientific communications organizations
- Experience interacting with journal editors, editorial boards, and leading scientific publications
- Global experience supporting multiple regions and cross-functional teams
Alnylam Pharmaceuticals Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Alnylam Pharmaceuticals and has not been reviewed or approved by Alnylam Pharmaceuticals.
-
Healthcare Strength — Alnylam Pharmaceuticals offers Blue Cross Blue Shield medical coverage with a choice of a PPO or an HDHP, and it funds the HDHP’s HSA ($750 for individual coverage or $1,500 for family coverage). Dental, vision, mental-health resources, and company-paid life and disability insurance round out a strong core health package.
-
Retirement Support — Alnylam Pharmaceuticals provides a Fidelity 401(k) with employer contributions, described as up to 6% when employees contribute at least 6% in one guide and a 4% match with automatic enrollment in another. Regardless of plan year, the availability of employer funding and auto-enrollment strengthens long-term savings support.
-
Wellbeing & Lifestyle Benefits — Alnylam Pharmaceuticals augments its package with up to $1,000 annually for eligible wellbeing expenses and up to 64 hours of paid Wellbeing Time. An Employee Assistance Program and other wellness resources further support day-to-day health and balance.
Alnylam Pharmaceuticals Insights
What We Do
Alnylam is a biopharmaceutical company pioneering RNA interference (RNAi) therapeutics, a gene-silencing approach designed to treat disease by disabling genes that cause or contribute to it. The company discovers, develops, and commercializes medicines based on RNAi, including approved therapies and a pipeline of investigational treatments. Its research targets both rare and prevalent diseases, with a mission to bring innovative medicines to patients.






